Search Results (62)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Fischer, Ryan | Person |
Why?
|
| Slowik, Voytek | Person |
Why?
|
| Nrf2 as a Master Regulator in Liver Disease Prevention and Therapy | Grant |
Why?
|
| Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease. | Academic Article |
Why?
|
| Fontan-Associated Liver Disease: Screening, Management, and Transplant Considerations. | Academic Article |
Why?
|
| Leukocyte cell-derived chemotaxin 2 correlates with pediatric non-alcoholic fatty liver disease. | Academic Article |
Why?
|
| Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study. | Academic Article |
Why?
|
| Non-alcoholic fatty liver disease in children: focus on nutritional interventions. | Academic Article |
Why?
|
| Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease. | Academic Article |
Why?
|
| The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease. | Academic Article |
Why?
|
| Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? | Academic Article |
Why?
|
| Treatment of non-alcoholic fatty liver disease in children: swim at your own risk. | Academic Article |
Why?
|
| End Stage Liver Disease | Concept |
Why?
|
| IMProving DRug dosing and Outcomes for single VEntricle patients with Fontan Associated Liver Disease (IMPROVE-FALD) | Grant |
Why?
|
| Liver Diseases | Concept |
Why?
|